Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1417924507
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
535 NW 9th St, Suite 235
Oklahoma City, OK, 73102
Phone (405) 272-6877
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,046 services
Medicare patients, 2024
615
Average age 72
Drug cost, 2024
$4.2M
2,890 prescriptions
Company payments, 2025
$2,656
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zahid F Cheema was code 99214 (office e&m - established), 350 times for 243 patients. In total Zahid F Cheema billed 2,046 services in 45 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 350 | 243 | $67.01 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 236 | 75 | $58.25 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 167 | 80 | $88.26 | $15K |
| 76942 Ultrasound - Nonspecific | Facility | 137 | 76 | $22.14 | $3,033 |
| 20526 Musculoskeletal | Facility | 125 | 66 | $54.81 | $6,851 |
| 95886 Electrical Nerve Conductivity | Facility | 117 | 80 | $33.07 | $3,869 |
| 99223 Hospital E&M - Initial | Facility | 98 | 95 | $124.55 | $12K |
| 99213 Office E&M - Established | Facility | 94 | 80 | $42.71 | $4,015 |
| 95816 Neurologic | Facility | 82 | 76 | $42.35 | $3,473 |
| 99291 Critical Care E&M | Facility | 61 | 12 | $157.81 | $9,627 |
| 95913 Electrical Nerve Conductivity | Facility | 51 | 50 | $135.90 | $6,931 |
| 95885 Electrical Nerve Conductivity | Facility | 50 | 44 | $13.71 | $686 |
| 99215 Office E&M - Established | Facility | 46 | 39 | $101.30 | $4,660 |
| 95819 Neurologic | Facility | 39 | 37 | $41.59 | $1,622 |
| 99204 Office E&M - New | Facility | 39 | 39 | $81.10 | $3,163 |
By year: 2022 $178K for 2,571 services; 2023 $147K for 2,130 services; 2024 $136K for 2,046 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zahid F Cheema prescribed most often to Medicare patients was Gabapentin, with 263 prescriptions and refills. In total Zahid F Cheema wrote 2,890 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 263 | 667 | 89 | $5,234 |
| Memantine Hcl Generic | 225 | 519 | 69 | $5,962 |
| Levetiracetam Generic | 162 | 402 | 46 | $5,512 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 126 | 130 | Under 11 | $1.3M |
| Tizanidine Hcl Generic | 111 | 230 | 35 | $898 |
| Enoxaparin Sodium Generic | 96 | 100 | Under 11 | $738 |
| Topiramate Generic | 95 | 245 | 31 | $1,437 |
| Donepezil Hcl Generic | 84 | 214 | 35 | $1,263 |
| Pregabalin Generic | 78 | 149 | 19 | $2,374 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 72 | 76 | Under 11 | $821K |
| Mycophenolate Mofetil Generic | 68 | 138 | 16 | $9,220 |
| Divalproex Sodium Er Divalproex Sodium | 64 | 155 | 22 | $3,843 |
| Primidone Generic | 62 | 154 | 20 | $1,297 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 59 | 59 | Under 11 | $510K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 58 | 157 | 17 | $2,369 |
Brand drugs: - claims; generic drugs: 2,351 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zahid F Cheema $2,656 ($2,656 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $371.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $371 |
| Argenx US, Inc. ARGX | 6 | $301 |
| UCB, Inc. UCB.BR | 17 | $280 |
| TG Therapeutics, Inc. TGTX | 4 | $232 |
| Pfizer Inc. PFE | 13 | $202 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $168 |
| Tanabe Pharma America, Inc. | 6 | $155 |
| Abbott Laboratories ABT | 1 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $129 |
| CSL Behring CSL.AX | 4 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.